TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

MEDIWOUND, LTD

GastroenterologyOncology
Biotech

MEDIWOUND, LTD is a biotechnology company focused on Gastroenterology, Oncology.

2022
Since
1
Drugs
-
Trials
1
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Gastroenterology 91%
0 drugs Phase 3: 1 Phase 2: 3
Oncology 9%
0 drugs Phase 1: 1

Pipeline Strength Pro

Loading...